Please Wait...

Alzheimer's & Parkinson's Diseases Congress - AD/PD 2019

March 26, 2019 - 1:00am (EDT) to March 31, 2019 - 1:00am (EDT)

Lisbon, Portugal

Bioclinica's scientific and medical imaging experts deploy advanced imaging techniques in the context of global clinical trials in Alzheimer’s and Parkinson’s Diseases. At this year’s 14th​ International Conference on Alzheimer's and Parkinson's Diseases (ADPD), our scientists are pleased to highlight Bioclinica contributions in oral presentations and scientific posters. Presentations will describe the use of baseline MRI to predict rapid DATscan progression, the importance of centrally reconstructing DATscan SPECT data, and our team’s experience with next-generation Tau tracers. Presentation details below.

Title: Longitudinal progression of DaTscan binding in Parkinson's Disease is associated with reduced regional brain volume at baseline
Authors: David Scott, PhD; Kate Adamczuk, PhD; Nicolas Pannetier, PhD; Mehul Sampat, PhD; Joël Schaerer, PhD; Luc Bracoud, MSc; Joyce Suhy, PhD
Presenter: David Scott, PhD
Session: Symposium 43: Biomarkers, Imaging in PD and LBD 1
Date: March 29

 

Title: Standardized DAT SPECT reconstruction decreases variance in Striatal Binding Ratios
Authors: Kate Adamczuk,PhD; Chris Conklin, PhD; Luc Bracoud, MSc; Nicolas Pannetier,PhD; Joyce Suhy,PhD; David Scott, PhD
Presenter: Kate Adamczuk, PhD
Date: On display March 27-28

 

Title: Evaluation of tau deposition in amyloid positive MCI or mild-AD dementia subjects from the elenbecestat MissionAD program using [18F]PI-2620 PET
Authors: Andrew Stephens; Santiago Bullich; Andre Mueller; Mathias Berndt; Susan De Santi; David Scott; Kate Adamczuk; Joyce Suhy; June Kaplow; Stephen Krause; Julia Chang; Bruce Albala; Johan Luthman
Presenters: A joint presentation by LMI, Eisai and Bioclinica 
Date: On display March 27-28

Visit event website

 

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Bioclinica SMART Our Digital Customer Portal Allows Sites and Sponsors to Benefit from Real-Time Access to Their Tr… https://t.co/VJi2kVttFu
Bioclinica (3 days ago)
Bioclinica will be gold sponsors at the upcoming World Drug Safety Congress in Europe. Meeting with our team to le… https://t.co/7efqU3ZHb8
Bioclinica (5 days ago)
Bioclinica Cardiac Safety Services Offered a Unique Solution for a Specific Regulatory Requirement. Read our case s… https://t.co/4j1AUk6YDz
Bioclinica (2 weeks ago)
Agile IRT is here! How can you benefit? Download our webinar to know more. #bioclinica #irt #clinicaltrials… https://t.co/zH5aFYxxUf
Bioclinica (2 weeks ago)
Bioclinica's Electronic Data Capture #EDC has been used in thousands of clinical studies worldwide. Why? Our single… https://t.co/g427VOUSFS
Bioclinica (2 weeks ago)
Bioclinica will be exhibiting at the upcoming #SCDM2019 – the industry’s largest clinical data management event of… https://t.co/JLTSWOI8rl
Bioclinica (2 weeks ago)